These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
318 related items for PubMed ID: 12823285
1. Bruton's tyrosine kinase defect in dendritic cells from X-linked agammaglobulinaemia patients does not influence their differentiation, maturation and antigen-presenting cell function. Gagliardi MC, Finocchi A, Orlandi P, Cursi L, Cancrini C, Moschese V, Miyawaki T, Rossi P. Clin Exp Immunol; 2003 Jul; 133(1):115-22. PubMed ID: 12823285 [Abstract] [Full Text] [Related]
5. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow. Jin Y, Fuller L, Ciancio G, Burke GW, Tzakis AG, Ricordi C, Miller J, Esquenzai V. Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764 [Abstract] [Full Text] [Related]
7. Type I and III Interferon Productions Are Impaired in X-Linked Agammaglobulinemia Patients Toward Poliovirus but Not Influenza Virus. Luk ADW, Ni K, Wu Y, Lam KT, Chan KW, Lee PP, Tu W, Mao H, Lau YL. Front Immunol; 2018 Feb; 9():1826. PubMed ID: 30147693 [Abstract] [Full Text] [Related]
9. Dendritic cells lose ability to present protein antigen after stimulating antigen-specific T cell responses, despite upregulation of MHC class II expression. Bernhard H, Huseby ES, Hand SL, Lohmann M, Batten WY, Disis ML, Gralow JR, Meyer zum Büschenfelde KH, Ohlén C, Cheever MA. Immunobiology; 2000 Apr; 201(5):568-82. PubMed ID: 10834314 [Abstract] [Full Text] [Related]
10. Bruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation. Lougaris V, Baronio M, Vitali M, Tampella G, Cattalini M, Tassone L, Soresina A, Badolato R, Plebani A. J Allergy Clin Immunol; 2014 Jun; 133(6):1644-50.e4. PubMed ID: 24612681 [Abstract] [Full Text] [Related]
12. Unimpaired activation of c-Jun NH2-terminal kinase (JNK) 1 upon CD40 stimulation in B cells of patients with X-linked agammaglobulinemia. Brunner C, Kreth HW, Ochs HD, Schuster V. J Clin Immunol; 2002 Jul; 22(4):244-51. PubMed ID: 12148599 [Abstract] [Full Text] [Related]
13. Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice. de Weers M, Mensink RG, Kraakman ME, Schuurman RK, Hendriks RW. Hum Mol Genet; 1994 Jan; 3(1):161-6. PubMed ID: 8162018 [Abstract] [Full Text] [Related]
14. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA). Zhu Q, Zhang M, Rawlings DJ, Vihinen M, Hagemann T, Saffran DC, Kwan SP, Nilsson L, Smith CI, Witte ON, Chen SH, Ochs HD. J Exp Med; 1994 Aug 01; 180(2):461-70. PubMed ID: 7519238 [Abstract] [Full Text] [Related]
18. Bruton's tyrosine kinase is present in normal platelets and its absence identifies patients with X-linked agammaglobulinaemia and carrier females. Futatani T, Watanabe C, Baba Y, Tsukada S, Ochs HD. Br J Haematol; 2001 Jul 30; 114(1):141-9. PubMed ID: 11472359 [Abstract] [Full Text] [Related]
19. Identification of a new Bruton's tyrosine kinase (BTK) mutation associated with a mild phenotype in a child with X-linked agammaglobulinemia (XLA). Staehelin F, Kühne T. Clin Lab Haematol; 2000 Apr 30; 22(2):123-5. PubMed ID: 10792406 [Abstract] [Full Text] [Related]
20. Tick saliva inhibits differentiation, maturation and function of murine bone-marrow-derived dendritic cells. Cavassani KA, Aliberti JC, Dias AR, Silva JS, Ferreira BR. Immunology; 2005 Feb 30; 114(2):235-45. PubMed ID: 15667568 [Abstract] [Full Text] [Related] Page: [Next] [New Search]